RLMD
Relmada Therapeutics, Inc. Common Stock
$6.73
0.00%
0.00
Notify me if price changes either direction
Buy RLMD stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
705.9M
Enterprise value
-41698832
Trailing PE
-4.6206895236311
Forward PE
-16.414635
PEG Ratio
0.074444442325168
Enterprise to EBITDA
3.01
Price to book MRQ
5.70339
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
EBITDA
-13855048
Diluted EPS TTM
-1.09
Total Cash (MRQ)
116.4M
Current ratio (MRQ)
80.214
Operating Cash Flow (TTM)
-12092784
RLMD trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
